Clinical Trials Logo

Clinical Trial Summary

The study will use blood (serum and plasma) and tissue obtained from participants undergoing prescribed surgical resection of vascular anomalies of interest proposed in this study. The study will also use blood (serum and plasma) and tissue collected and stored in a tissue bank maintained by the Department of Hematology/Oncology.


Clinical Trial Description

While vascular anomalies are rare diseases, they can be life-threatening and devastating to affected children and their families. Advances in diagnosis, monitoring and therapies will be significantly improved if non-invasive biomarkers that are sensitive and specific can be identified. Obtaining a tissue biopsy to help in diagnosis can actually worsen the disease and so identification of specific blood biomarkers is highly desirable. Studies will measure angiogenic factors in serum and plasma samples at baseline and on therapy. Tissue removed during surgical resection or blood removed prior to sclerotherapy will be used to obtain cells and tissue for the assessment of where biomarkers are coming from and to identify disease-causing pathways for new therapeutic targeting. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03001180
Study type Observational
Source Children's Hospital Medical Center, Cincinnati
Contact Timothy LeCras, PhD
Phone 5138034862
Email hvmcresearch@cchmc.org
Status Recruiting
Phase
Start date April 2015
Completion date December 2050

See also
  Status Clinical Trial Phase
Completed NCT03583307 - Efficacy and Safety of Sirolimus to Vascular Anomalies N/A
Not yet recruiting NCT04194619 - Pregnancy in Women With Rare Multisystemic Vascular Diseases: COGRare5 Study
Enrolling by invitation NCT00833599 - Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders
Recruiting NCT04464655 - A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease
Completed NCT04836884 - Vascular Anomaly Pathology and Genomics Biopsy Study N/A
Not yet recruiting NCT05983159 - A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations Phase 2
Recruiting NCT04172922 - Topical Rapamycin/Sirolimus for Complicated Vascular Anomalies and Other Susceptible Lesions Phase 1